Trial intelligence / Profile preview

Effect of naloxone and methylnaltrexone on satiety, gastric sensitivity, and accommodation to food in healthy volunteers

2009-017193-20Phase 4Completed

Sponsor
UZ Leuven
Start
Jan 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of naloxone and methylnaltrexone, sponsored by UZ Leuven. Primary endpoint: liquid nutrient tolerance to reach maximum satiation. Started Jan 2010; status: completed.

02

Drugs

naloxonemethylnaltrexone

Beyond the preview

Go deeper on 2009-017193-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017193-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call